Neuralgia Clinical Trial
Official title:
The Effect of Soy Protein on Neuropathic Pain: Randomized N-of-1 Trials
Neuropathic pain is one form of chronic pain lacking effective pharmacotherapy. Interest in the role of complementary and alternative medicine is growing and diet is at the forefront of the search for alternative treatments for pain. Soy protein is one of the most promising dietary ingredients tested for its pain-relieving properties. Results from animal studies show that soy-enriched diets reduce pain due to nerve injury. The purpose of this study is to determine the effects of soy protein supplementation on facial pain.
Neuropathic pain is a complex disorder with mixed results in response to pain medication due to a high degree of variability between patients. To address this issue, we are implementing a unique methodology using a series of N-of-1 or single subject randomized, double blind, controlled studies. With this, we will explore the role of soy protein supplementation in neuropathic pain patients. Each patient will be exposed in 3-week intervals to soy protein and a control, milk protein, in three paired treatment periods for a total of 18 weeks. This method allows for the measurement of treatment efficacy in individual distinct patients and has the potential for immediate and continued medical benefit using a simple and readily available dietary ingredient. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04066933 -
Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
|
||
| Completed |
NCT01202227 -
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
|
Phase 3 | |
| Completed |
NCT00922987 -
Clinical Study With Lyrica In Patients Suffering From Epilepsy
|
||
| Terminated |
NCT00964990 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
|
Phase 2 | |
| Recruiting |
NCT00740571 -
Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer
|
Phase 3 | |
| Terminated |
NCT02747758 -
Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy
|
N/A | |
| Completed |
NCT05464199 -
Home-based EEG Neurofeedback for Chronic Neuropathic Pain
|
Phase 1 | |
| Completed |
NCT02490436 -
Novel Treatment Option for Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT01974791 -
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT01279018 -
Persistent Pain After Breast Cancer Treatment With Docetaxel
|
N/A | |
| Not yet recruiting |
NCT00944502 -
To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins
|
Phase 3 | |
| Completed |
NCT02957851 -
EMONO for the Treatment of Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT02180880 -
Symptom Based Treatment of Neuropathic Pain
|
Phase 4 | |
| Active, not recruiting |
NCT01508676 -
Effects of Pennsaid on Clinical Neuropathic Pain
|
N/A | |
| Completed |
NCT00631943 -
A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain
|
Phase 3 | |
| Completed |
NCT03973983 -
Comparison of Ultrasound-guided Transgluteal and Finger-guided Transvaginal Pudendal Nerve Block Techniques
|
N/A | |
| Terminated |
NCT03296111 -
Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life
|
||
| Not yet recruiting |
NCT06398847 -
Virtual Reality (VR) Self-Hypnosis Software
|
N/A | |
| Terminated |
NCT02460107 -
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
|
Early Phase 1 | |
| Recruiting |
NCT01788410 -
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
|